<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McGrath KE</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Heart, Lung, and Blood Institute</funding><funding>U.S. Department of Health &amp; Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes &amp; Digestive &amp; Kidney Diseases)</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases</funding><pagination>7619</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12356964</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>The limited proliferative capacity of erythroid precursors is a major obstacle to generate sufficient in vitro-derived red blood cells for clinical purposes. While BMI1, a Polycomb Repressive Complex 1 member, is both necessary and sufficient to drive extensive proliferation of self-renewing erythroblasts, its mechanism of action remains poorly understood. Here we report that BMI1 overexpression leads to 10 billion-fold increase in self-renewal of human erythroblasts, which can terminally mature and agglutinate with typing reagent monoclonal antibodies. BMI1 and RING1B occupancy, along with repressive histone marks, are present at known BMI1 target genes, including the INK-ARF locus, consistent with altered cell cycle kinetics following BMI1 inhibition. Upregulation of BMI1 target genes wi</pubmed_abstract><journal>Nature communications</journal><pubmed_title>BMI1 regulates human erythroid self-renewal through both gene repression and gene activation.</pubmed_title><pmcid>PMC12356964</pmcid><funding_grant_id>UL1 TR002001</funding_grant_id><funding_grant_id>DK124777</funding_grant_id><funding_grant_id>U01 HL134696</funding_grant_id><funding_grant_id>R01 DK104920</funding_grant_id><funding_grant_id>R01 HL130670</funding_grant_id><funding_grant_id>DK104920</funding_grant_id><funding_grant_id>R01 DK124777</funding_grant_id><funding_grant_id>R35 HL171168</funding_grant_id><funding_grant_id>U54 DK106857</funding_grant_id><pubmed_authors>Koniski AD</pubmed_authors><pubmed_authors>Westhoff CM</pubmed_authors><pubmed_authors>McGrath KE</pubmed_authors><pubmed_authors>Carlson TL</pubmed_authors><pubmed_authors>Blanc L</pubmed_authors><pubmed_authors>Kingsley PD</pubmed_authors><pubmed_authors>Steiner LA</pubmed_authors><pubmed_authors>Schulz VP</pubmed_authors><pubmed_authors>Gallagher PG</pubmed_authors><pubmed_authors>Palis J</pubmed_authors><pubmed_authors>An HH</pubmed_authors><pubmed_authors>Murphy KE</pubmed_authors><pubmed_authors>Kim AR</pubmed_authors><pubmed_authors>Getman M</pubmed_authors><pubmed_authors>Papoin J</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Chou ST</pubmed_authors><pubmed_authors>Olsen JL</pubmed_authors></additional><is_claimable>false</is_claimable><name>BMI1 regulates human erythroid self-renewal through both gene repression and gene activation.</name><description>The limited proliferative capacity of erythroid precursors is a major obstacle to generate sufficient in vitro-derived red blood cells for clinical purposes. While BMI1, a Polycomb Repressive Complex 1 member, is both necessary and sufficient to drive extensive proliferation of self-renewing erythroblasts, its mechanism of action remains poorly understood. Here we report that BMI1 overexpression leads to 10 billion-fold increase in self-renewal of human erythroblasts, which can terminally mature and agglutinate with typing reagent monoclonal antibodies. BMI1 and RING1B occupancy, along with repressive histone marks, are present at known BMI1 target genes, including the INK-ARF locus, consistent with altered cell cycle kinetics following BMI1 inhibition. Upregulation of BMI1 target genes wi</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-07-15T12:39:50.005Z</modification><creation>2026-07-04T03:14:35.755Z</creation></dates><accession>S-EPMC12356964</accession><cross_references><pubmed>40817093</pubmed><doi>10.1038/s41467-025-62993-3</doi></cross_references></HashMap>